Real-World Treatment Study of Koselugo (Selumetinib)

Trial Identifier:	D1346R00009
Sponsor:	AstraZeneca
Start Date:	June 2024
Primary Completion Date:	September 2031
Study Completion Date:	September 2031

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.